Giuseppina Uccello

Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network

Concetta Conticello, Alessandra Romano, Vittorio Del Fabro et al. · Journal of Clinical Medicine · 2019 · 27 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia

Francesca Romana Mauro, Fortunato Morabito, Iolanda Donatella Vincelli et al. · Leukemia Research · 2017 · 23 citations

Medicine, Hematology, Immunology +13

Lenalidomide and low‐dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials

Massimo Gentile, Valeria Magarotto, Massimo Offidani et al. · American Journal of Hematology · 2016 · 20 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials

Massimo Gentile, Ernesto Vigna, Salvatore Palmieri et al. · Haematologica · 2023 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials

Antonella Bruzzese, Daniele Derudas, Mónica Galli et al. · Hematological Oncology · 2022 · 16 citations · Full text

Medicine, Oncology, Pharmacotherapy +17